About
Kumquat Biosciences develops small molecule and immuno-oncology therapies targeting the KRAS pathway to treat cancers with currently undruggable mutations, focusing on combining targeted and immune-based approaches for durable therapeutic effects.
Explore Kumquat Biosciences's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.